Cytori hits the capital raise button; shares down 14% after hours

|About: Cytori Therapeutics Inc (CYTX)|By:, SA News Editor

After a 25.55% advance during the regular session on good FDA news, Cytori Therapeutics (NASDAQ:CYTX) launches a secondary offering. The size of the sale isn't disclosed.

Shares -14.5% after hours